http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016038929-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_268be9afa00cf55b5aa72b1612151ecb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6874
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6806
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
filingDate 2015-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f873690b7796888d56a947fb9861aa3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8403eee0ad0c5d9f347988d02ff6bed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_764d25260215d8a05e7e85187d5cb3c0
publicationDate 2016-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2016038929-A1
titleOfInvention Method for detecting presence/absence of fetal chromosomal aneuploidy
abstract A method for detecting the presence/absence of a fetal chromosomal aneuploidy, said method comprising a first amplification step for amplifying chromosomal DNA obtained from a biological sample that is collected from a pregnant woman to give a first amplification product, a second amplification step for multiplex amplifying a plurality of target regions with the use of the first amplification product as a template to give a second amplification product, a step for labeling both ends of the second amplification product to give a labeled second amplification product, a third amplification step for using a primer pair annealing to the labels and performing amplification with the use of the labeled second amplification product as a template to give a third amplification product, and a step for determining the base sequence and amplification amount of the target regions from the third amplification product, wherein the amplification in the first amplification step is 6,000- to 30,000-fold in terms of the total DNA amount, and the amplification in the second amplification step is 3- to 150-fold in terms of the total DNA amount.
priorityDate 2014-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013057568-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013075100-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007147073-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014099919-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9TKU7
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID448124
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ06SH2
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415968521
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1KVQ9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ20EU8

Total number of triples: 29.